0000899243-19-003022.txt : 20190208 0000899243-19-003022.hdr.sgml : 20190208 20190208161529 ACCESSION NUMBER: 0000899243-19-003022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190207 FILED AS OF DATE: 20190208 DATE AS OF CHANGE: 20190208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liang Hong CENTRAL INDEX KEY: 0001754627 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38682 FILM NUMBER: 19580068 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kodiak Sciences Inc. CENTRAL INDEX KEY: 0001468748 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270476525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-281-0850 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: Oligasis, LLC DATE OF NAME CHANGE: 20090721 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-07 0 0001468748 Kodiak Sciences Inc. KOD 0001754627 Liang Hong 2631 HANOVER STREET PALO ALTO CA 94304 0 1 0 0 See Remarks Common Stock 2019-02-07 4 M 0 80000 1.04 A 100000 D Stock Option (Right to Buy) 1.04 2019-02-07 4 M 0 80000 0.00 D 2026-06-23 Common Stock 80000 32000 D The Reporting Person entered into a Lock-up Agreement in favor of the underwriters of the Company's initial public offering in October 2018 (the "Lock-up"). The terms of the Lock-up permit the exercise of options by the Reporting Person for cash and the shares of common stock issued as a result of the exercise are subject to the terms of the Lock-up. No shares of common stock were sold by the Reporting Person in connection with the exercise. The Reporting Person was originally granted an option to purchase 132,000 shares. Twenty-Five percent of the shares subject to the option vested on December 7, 2016, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. On August 30, 2018, the Reporting Person exercised 20,000 of those shares and on February 7, 2019, the Reporting Person exercised 80,000 of those shares. Senior Vice President, Discovery Medicine /s/Barbara A. Mery, Attorney-in-fact for Hong Liang 2019-02-08